Context

Indian Immunologicals Limited, a wholly owned subsidiary of the National Dairy Development Board has finished the first phase of clinical trials of dengue vaccine to determine the safety of the vaccine. The vaccine could be available commercially as early as mid-2026.

About

About Dengue

• Dengue (break-bone fever) is a viral infection that spreads from mosquitoes (Aedes aegypti mosquito) to people. It is more common in tropical and subtropical climates.
• Symptoms: High fever, headache, body aches, nausea and rash.
• Treatment: There is no specific treatment for dengue. In severe cases, dengue can be fatal. 
• Global burden: There are around 100–400 million infections per year and nearly half the world's population is at risk.